Trial Profile
A randomized study to evaluate the effect combined cataract surgery and ranibizumab injection in postoperative macular edema in nonproliferative diabetic retinopathy.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Dec 2015
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 01 Dec 2015 New trial record